(Q79967580)

English

Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

scientific article published on 01 May 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

author name string

David J Straus

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Madeleine Duvic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Timothy Kuzel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Steven Horwitz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marie-France Demierre

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Patricia Myskowski

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Steven Steckel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1799-1803

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Immunopathogenesis and therapy of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment modalities in cutaneous T-cell lymphoma (CTCL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing bexarotene therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoid receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological effects of bexarotene in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Roferon-A (interferon alpha 2a) combined with Tigason (etretinate) for treatment of cutaneous T cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22596

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22596

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366595%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79967580&oldid=2108676025"